Abstract
Macrophages can fuse to form osteoclasts in bone ormultinucleate giant cells (MGCs) as part of the immune response. We use a systems genetics approach in rat macrophages to unravel their genetic determinants of multinucleation and investigate their role in both bone homeostasis and inflammatory disease. We identify a trans-regulated gene network associated with macrophage multinucleation and Kcnn4 as being the most significantly trans-regulated gene in the network and induced at the onset of fusion. Kcnn4 is required for osteoclast and MGCformation in rodents and humans. Genetic deletion of Kcnn4 reduces macrophage multinucleation through modulation of Ca2+ signaling, increases bone mass, and improves clinical outcome in arthritis. Pharmacological blockade of Kcnn4 reduces experimental glomerulonephritis. Our data implicate Kcnn4 in macrophage multinucleation, identifying it as a potential therapeutic target for inhibition of bone resorption and chronic inflammation.
Original language | English (US) |
---|---|
Pages (from-to) | 1210-1224 |
Number of pages | 15 |
Journal | Cell reports |
Volume | 8 |
Issue number | 4 |
DOIs | |
State | Published - Aug 21 2014 |
Funding
The authors are grateful to Veterinary Clinical Services at the Yale School of Medicine and to the Yale Core Center for Musculoskeletal Diseases, in particular, to Nancy Troiano for her assistance in processing the mouse bones for histomorphometry analysis. We also thank Bolder Biopath (Boulder, CO) for processing the arthritic mouse bones for histology, and grading the pathology. We would like to thank Jennifer Smith for her excellent technical assistance and Kathrin Saar (MDC, Berlin) for genotyping protocols and data analysis. We gratefully acknowledge funding from Kidney Research UK (RP9/2013) (J.B.), Wellcome Trust (WT092523MA) (J.B.). We also acknowledge funding from the European Community\u2019s Seventh Framework Programme (FP7/2007\u20132013) under grant agreement no. HEALTH-F4- 2010-241504 (EURATRANS) (E.P. and M.R.) and the Medical Research Council (E.P.). A.H., J.D., J.Z., D.S., A.K.B., G.N., and J.L. are employees of Boehringer Ingelheim. This work was supported in part by a grant from Boehringer Ingelheim.
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology